# Health Gene Technologies Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/health-gene-technologies-co

- Industry: Medical Devices & Equipment
- Headquarters: Ningbo, China
- Website: www.healthgenetech.net
- Total disclosed funding: $34M
- Latest round: Series C (Aug 8, 2022)
- Investors on record: 10

## About

Established in 2011 and based in Ningbo, China, Health Gene Technologies Co., Ltd is a total solution provider of nucleic acid assays for precision medicine, individual identification, and other fields. The company has a 2,000-square-meter molecular diagnostic research and development laboratory and a 6,000-square-meter GMP-standard 100,000-grade production purification plant, with nearly 70 research and development staff, and is one of the largest suppliers of forensic DNA testing reagents in China. The company has also received honors such as Science and Technology Small and Medium Enterprises of Zhejiang Province.

The company mainly develops and produces nucleic acid testing products, the main products are kits, including court science series and precision medicine series. The products in the Court Science series include SurelD® C32 human DNA identification kits, etc., which, together with the company's DNA database testing solutions, can provide technical support for cases involving DNA testing. The Precision Medicine series includes 13 respiratory pathogens multiplex kits, etc., which can provide technical support for the detection of coronavirus, etc.

## Funding rounds

- Series C, Aug 8, 2022 — Shenzhen Capital Real Estate Fund, Hangzhou Binjiang Puhua Equity Investment Management, BioTrack Capital, Ningbo Industrial Investment Group Co., Ltd, Ningbo Yin Gong Venture Capital Partnership
- Series B, Jun 28, 2022 — Jinyuan Kuntong Equity Investment Management
- Series A, Dec 1, 2020, $34M — Qiming Venture Partners, GL Capital Group, Blue Lake Capital, Prosperico Ventures, BioTrack Capital

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- GL Capital Group (https://capitalatlas.ai/funds/gl-capital-group) — Series A
- Blue Lake Capital (https://capitalatlas.ai/funds/blue-lake-capital) — Series A
- Prosperico Ventures (https://capitalatlas.ai/funds/prosperico-ventures) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A, Series C
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series B
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series C
- Hangzhou Binjiang Puhua Equity Investment Management — Series C
- Ningbo Industrial Investment Group Co., Ltd — Series C
- Ningbo Yin Gong Venture Capital Partnership — Series C